Home

Hektar Opfern Ein Gläubiger ceo pfizer net worth bitter warum nicht Botschaft

Pfizer CEO Albert Bourla on developing a COVID vaccine in less than a year  | Fortune
Pfizer CEO Albert Bourla on developing a COVID vaccine in less than a year | Fortune

Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see  more | S&P Global Market Intelligence
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence

Ex-Pfizer CEO Ian Read sees 2018 pay slashed by a third as incentive  package plummets | Fierce Pharma
Ex-Pfizer CEO Ian Read sees 2018 pay slashed by a third as incentive package plummets | Fierce Pharma

10 US marijuana CEOs get million-dollar pay in 2020 as disclosure practices  questioned
10 US marijuana CEOs get million-dollar pay in 2020 as disclosure practices questioned

Albert Bourla - Chief Executive Officer - Pfizer | LinkedIn
Albert Bourla - Chief Executive Officer - Pfizer | LinkedIn

Covid vaccine profits mint 9 new pharma billionaires | CNN Business
Covid vaccine profits mint 9 new pharma billionaires | CNN Business

Ugur Sahin
Ugur Sahin

Wir sind Pfizer Deutschland
Wir sind Pfizer Deutschland

Pfizer chief sold $5.6m of shares as investors hailed vaccine | Financial  Times
Pfizer chief sold $5.6m of shares as investors hailed vaccine | Financial Times

Pfizer CEO: What's next for vaccines, tech and the pandemic | World  Economic Forum
Pfizer CEO: What's next for vaccines, tech and the pandemic | World Economic Forum

Meet Married BioNTech Billionaires Who Helped Create Pfizer Vaccine
Meet Married BioNTech Billionaires Who Helped Create Pfizer Vaccine

Albert Bourla: Net Worth, Biography, Age, Career, Salary & More - MTM
Albert Bourla: Net Worth, Biography, Age, Career, Salary & More - MTM

Pfizer CEO Albert Bourla sold stock the day he announced promising vaccine  news | CNN Business
Pfizer CEO Albert Bourla sold stock the day he announced promising vaccine news | CNN Business

Pfizer CEO gets 61% pay raise—to $27.9 million—as drug prices continue to  climb | Ars Technica
Pfizer CEO gets 61% pay raise—to $27.9 million—as drug prices continue to climb | Ars Technica

Pfizer CEO on Omicron Variant and Vaccine Efficacy
Pfizer CEO on Omicron Variant and Vaccine Efficacy

Albert Bourla - STAT
Albert Bourla - STAT

Pfizer (PFE) CEO Albert Bourla, Pharma Executives Sell Stock in Covid Rally  - Bloomberg
Pfizer (PFE) CEO Albert Bourla, Pharma Executives Sell Stock in Covid Rally - Bloomberg

Why the Pfizer CEO selling 62% of his stock the same day as the vaccine  announcement looks bad | Financial Post
Why the Pfizer CEO selling 62% of his stock the same day as the vaccine announcement looks bad | Financial Post

Pfizer hands CEO massive pay raise—plus $8M bonus—to dissuade him from  retiring | Fierce Pharma
Pfizer hands CEO massive pay raise—plus $8M bonus—to dissuade him from retiring | Fierce Pharma

Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became  Pandemic Billionaires In 2020
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020

Albert Bourla - Wikipedia
Albert Bourla - Wikipedia

Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly  legally—as COVID-19 vaccine data lift market | Fierce Pharma
Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID-19 vaccine data lift market | Fierce Pharma

Chief executives of mRNA vaccine groups earned $100mn in pandemic pay |  Financial Times
Chief executives of mRNA vaccine groups earned $100mn in pandemic pay | Financial Times

Three Billionaires Behind Pfizer's Vaccine Partner BioNTech Are $2 Billion  Richer After It Announces Covid-19 Vaccine Results
Three Billionaires Behind Pfizer's Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine Results

Pfizer CEO Albert Bourla received $24.3 million in total compensation for  2021
Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021

Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see  more | S&P Global Market Intelligence
Pfizer expects $15B in COVID-19 vaccine sales in 2021; some analysts see more | S&P Global Market Intelligence

The CEO of Pfizer on Developing a Vaccine in Record Time
The CEO of Pfizer on Developing a Vaccine in Record Time